Is the levonorgestrel-releasing intrauterine system (LNG IUD) a progestin-only contraceptive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, the levonorgestrel-releasing intrauterine system (LNG-IUD) is a progestin-only contraceptive.

The LNG-IUD releases only levonorgestrel, a synthetic progestin, without any estrogen component, making it definitively a progestin-only contraceptive method. 1, 2, 3

Mechanism and Classification

The LNG-IUD works through local progestin delivery directly to the endometrium, achieving:

  • Local endometrial suppression - causing endometrial thinning, glandular atrophy, and stromal decidualization
  • Cervical mucus thickening - creating a barrier to sperm penetration
  • Prevention of fertilization - primarily by inhibiting sperm motility, not by preventing implantation 4, 5

Importantly, the LNG-IUD does not suppress ovulation in most users, unlike combined hormonal contraceptives. This distinguishes it from estrogen-containing methods while confirming its progestin-only classification 5.

Systemic Hormone Levels

The locally released levonorgestrel creates:

  • Endometrial concentrations 200-800 times higher than oral progestin use
  • Plasma levels lower than other levonorgestrel-containing contraceptives 5

This localized delivery explains why the LNG-IUD is recommended over combined estrogen-progestin contraceptives in specific high-risk populations where estrogen is contraindicated 6.

Clinical Implications of Progestin-Only Status

Because the LNG-IUD contains only progestin, it is:

  • Strongly recommended for women with antiphospholipid antibodies (where estrogen is absolutely contraindicated due to thrombosis risk) 6
  • Preferred for SLE patients with moderate/severe disease activity over combined hormonal methods 6
  • Safe for breastfeeding women without concerns about estrogen effects on lactation 3
  • Appropriate for women with estrogen contraindications including history of VTE, migraine with aura, or cardiovascular disease 1

The progestin-only nature means VTE risk is not increased (RR 0.61,95% CI 0.24-1.53) compared to the elevated risk with estrogen-containing contraceptives 6, 7.

Available Formulations

Multiple LNG-IUD products exist in the U.S., all containing only levonorgestrel:

  • 52 mg levonorgestrel (Mirena, Liletta) - approved for 5 years, effective up to 7 years
  • 13.5 mg levonorgestrel (Skyla) - approved for 3 years 2, 3

All are progestin-only devices without estrogen.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.